Goal: The goal of this bulletin is to provide information and/or updates on issues regarding adulteration of goldenseal (Hydrastis Canadensis) root to the international herbal industry and extended natural products community in general. It is intended to present the available data on the occurrence of adulteration, the market situation, and consequences for the consumer and the industry.
1 General Information
1.1 Common name: Goldenseal1,2
1.2 Other common names:
English: Yellow root, yellow puccoon, ground raspberry, wild curcuma*, Indian dye, eye root, eye balm, Indian paint, jaundice root, Warnera3,4
French: Hydraste du Canada, hydraste, fard inolien, framboise de terre, sceau d’or5
German: Goldsiegelwurzel, Kanadische Gelbwurz, Kanadische Orangenwurzel5
Italian: Idraste, radice gialla6
Spanish: Hidrastis, hidrastis de Canadá, raíz de oro, scello de oro5
1.3 Accepted Latin binomial: Hydrastis canadensis7,8
1.4 Botanical family: Ranunculaceae
1.5 Plant part and form: Whole fresh or dry roots and rhizomes, powdered dry roots and rhizomes, hydroalcoholic and glycerin-water extracts and powdered dry extracts.9,10 Dried whole or powdered roots and rhizomes complying with the United States Pharmacopeia (USP) are required to contain not less than 2.0% of hydrastine and not less than 2.5% berberine.10
1.6 General use(s): Native American tribes used goldenseal root and rhizome preparations as eye washes, treatments for skin disorders, bitter tonics, and for respiratory ailments and the infectious diseases brought by European settlers.11 The plant was included in The American Eclectic Materia Medica and Therapeutics12 and King’s American Dispensatory,13 which increased its use substantially among Eclectic physicians for infections, mouth ulcers, and thrush, inflamed mucous membranes, chronic gonorrhea, jaundice, gastrointestinal complaints, as a bitter tonic and as a uterine tonic. Goldenseal preparations are now used as antimicrobial agents to treat infections of the mucosal membrane, including mouth, upper respiratory tract, gastrointestinal tract, eyes, vagina, as well as for wounds.9
2.1 Importance of the trade: Echinacea-goldenseal combination dietary supplements were ranked #15 in sales in the natural food channel in the United States in 2013 and in 2014 (Table 1), with estimated sales exceeding $5 million in 2014. Sales in the Mainstream Multi-Outlet retail channel (excluding sales data from Walmart and Club stores in 2013 and 2014, which were not available) were lower, with echinacea-goldenseal products ranking between #41 and #53. (T. Smith [American Botanical Council] e-mail to S. Gafner, September 2, 2015, and September 3, 2015)14,15
Goldenseal root/rhizome-only supplements did not rank in the top 50 best-selling herbal supplements in the natural food channel or the Mainstream Multi-Outlet retail channel from 2012-2014 (Table 2).
Table 1: Sales data for echinacea-goldenseal dietary supplements from 2012-2014.
|Rank||Sales [US$]||Rank||Sales [US$]||Rank||Sales [US$]|
Table 2: Sales data for goldenseal-only dietary supplements from 2012-2014.
|Rank||Sales [US$]||Rank||Sales [US$]||Rank||Sales [US$]|
|Mainstream Multi-Outletb||60||1,287, 453||106||217,617||102||207,312|
aAccording to SPINS (SPINS does not track Whole Foods Market sales, which is a major natural products retailer in the US)
bAccording to SPINS/IRI (the Mainstream Multi-Outlet channel was formerly known as food, drug and mass market channel [FDM]; possible sales at Walmart and Club stores are excluded in 2013 and 2014)
n/a: not available
Source: T. Smith (American Botanical Council) e-mail September 2, 2015, and September 3, 2015
2.2 Supply sources: Historically, the majority of the goldenseal root and rhizome on the market has come from the wild-harvested material, with Kentucky and Tennessee as the major producers. Other states along the Appalachian Mountains and in the northeastern United States provide additional supplies.9 There is no credible evidence that H. Canadensis is cultivated commercially outside of the United States and Canada.
2.3 Conservation status: In 1997 goldenseal was listed on Appendix II of the Convention on International Trade in Endangered Species of Wild Fauna and Flora,17 which also controls global trade and markets for H. Canadensis.18 Several states consider H. Canadensis in need of conservation: Pennsylvania lists the plant as vulnerable, at high risk of endangerment in the wild; Maryland, Michigan and New York list the plant as threatened, at risk of extinction in the wild sometime in the near future; Connecticut, Georgia, Massachusetts, Minnesota, New Jersey and Vermont list the plant as endangered, at high risk of extinction in the wild; North Carolina and Tennessee list the plant as endangered with special concern, at critically high risk of extinction in the wild.19
2.4 Raw material forms: Bulk goldenseal root and rhizome raw material is sold as whole roots and rhizomes (fresh or dry), cut and sifted, or as a powder.
2.5 Market dynamics: Despite a general trend of price increases since 1986, the costs vary considerably from year to year. Prices per kg paid to collectors of dried wild goldenseal root and rhizome ranged from the US $44–$77 between 1996 and 2005, and $77 wild to $110 for organic woods-cultivated material for the same time frame.20 The price per kg of dried wild root and rhizome peaked at $77 in 2001, dropping to $44 per kg in 2005, and fluctuating between $44–55 per kg through 2010.21 In its tonnage report, the American Herbal Products Association (AHPA) reported an average yearly harvest of 10 metric tons (MT) of cultivated compared to 30 MT of wild-harvested dry goldenseal root and rhizome between 2004 and 2010. The amounts of fresh goldenseal root and rhizome have remained below one MT in the same timeframe. Generally, the quantities of goldenseal root and rhizome harvested between 2004 and 2010 have been relatively steady.22
3.1 Historical adulterants: At the height of the Eclectic medical movement in the United States during the early 1900s, the price of goldenseal had risen to the point that several plant species were being used as economic adulterants on a regular basis; these included goldthread or coptis (Coptis spp., Ranunculaceae), yellow root (Xanthorrhiza simplicissima, Ranunculaceae), European peony (Paeonia Officinalis, Paeoniaceae),and twin leaf (Jeffersonia diphylla, Berberidaceae).23,24 The adulteration of goldenseal with Virginia snakeroot (Aristolochia serpentaria, Aristolochiaceae), which is of concern due to its content of nephrotoxic and carcinogenic aristolochic acids, was initially documented in 1892 and described again in 1900.25 However, there are no reported cases of adulteration with Virginia snakeroot in recent times. Additional historical adulterants and contaminants of goldenseal that have been documented include Athyrium filix-femina (Athyriaceae), Stylophorum diphyllum (Papaveraceae), Cypripedium calceolus(Orchidaceae), Collinsonia canadensis (Lamiaceae), Trillium spp. (Melanthiaceae), Caulophyllum thalictroides (Berberidaceae), and Polygala senega (Polygalaceae) as admixtures or contaminants.26 It is unlikely that adulteration is occurring with these species in commerce today.
3.2 Recent adulterants: Over the past 20–30 years, economic adulterants have reappeared in goldenseal products,27-29 based in part on the erroneous use of goldenseal to negate illicit drug testing in the 1980s.30 The adulterating species include Japanese goldthread (Coptis japonica), yellow root (Xanthorrhizasimplicissima), Oregon grape (Mahonia aquifolium, Berberidaceae), celandine (Chelidonium majus, Papaveraceae), barberry (Berberis spp., Berberidaceae), and yellow dock (Rumex spp., Polygonaceae) root.2,9,27 There is a single case of the sale of other root materials labeled as goldenseal, e.g., plantain (Plantago spp., Plantaginaceae) root, nettle (Urtica dioica, Urticaceae) root, or passionflower (Passiflora incarnata, Passifloraceae) root colored with a yellow dye, as reported on the website of an analytical laboratory.31
Historically, market pricing for H. Canadensis has displayed instability.20 As noted above, over the more recent 15 years the price has ranged between $44-110/kg for dry root and rhizome material. Assuming that the relatively higher goldenseal price level drives intentional economic adulteration, the addition and/or substitution with several of the adulterating plant species would represent substantial cost savings to an unscrupulous supplier. Over the past 20 years, dried roots of the species Mahonia have sold at $6.1-$8.8 per kg and Berberis at $7.3-14.30 per kg. Over the past 10 years, the price/kg of adulterating species ranged as follows: celandine $3.7-6.9, barberry $5.6-19.3, yellow dock imported $9.5-10.1 and domestically grown $12.9-14.8. (S. Yeager [Mountain Rose Herbs] e-mail, August 25, 2015) The price/kg for Coptis spp. was approximate $14.1 per kg in 2011 and $11.0/kg in 2015.32
3.3 Sources of information supporting confirmation of adulteration: Goldenseal adulteration can be detected through the presence or absence of several alkaloids, namely the presence of berberine, canadine, hydrastine, and hydrastinine, and the absence of palmatine.9 Although most species used as adulterants contain berberine, the alkaloids hydrastine and canadine are unique to goldenseal.9 The presence of palmatine is indicative of adulteration by Coptis spp., the most common adulterant of goldenseal.27 An analysis of several dietary supplement products marketed as goldenseal root extract using the AOAC official method 2008.04-2008, a high-performance liquid chromatography (HPLC) method for the analysis of goldenseal material, revealed that several products contained palmatine.33
A validated HPLC-mass spectrometry (MS) method was used to analyze H. Canadensis root from three suppliers along with the common adulterants – Coptis spp. root, M. aquifolium root, Berberis spp. bark, and C. majus herb.29 Of the three commercial lots that were purchased, all contained the expected goldenseal alkaloids: hydrastinine berberastine, tetrahydroberberastine, canadaline, berberine, hydrastine, and canadine. However, one product contained additional alkaloids not associated with goldenseal – palmatine, coptisine, and jatrorrhizine – thus suggesting admixture of an adulterating species. Avula et al. used an ultra-high-performance liquid chromatography (UHPLC) method to detect the non-goldenseal constituents palmatine, coptisine, and jatrorrhizine in a commercial goldenseal product.34 An emerging adulterant problem stems from the use of goldenseal leaf material, which contains both berberine and hydrastine, but in a different ratio from goldenseal root.27
A recent report by a company specializing in DNA-based species identification analyzed several off-the-shelf goldenseal products, including those from a company described as “a major manufacturer.” The company used their proprietary ConfirmIDNATM method, a DNA barcoding method using universal primers, to identify plantain root, nettle root, or passionflower root rather than goldenseal. In addition, the product was colored with a yellow dye.31 No additional tests were carried out to confirm these findings.
Although this publication is focused on H. Canadensis root, commercial trade in H. Canadensis leaf does occur. Dried leaf harvest for the years 2004-2010 was estimated to range from 3.5-8.5 MT.22 During that time the price was approximate $2.2-11.0/kg (E. Burkhart [Pennsylvania State University] e-mail, September 21, 2012). Goldenseal leaf is an article of commerce, and there are allegations of its use as a low-cost adulterant.27 Actual evidence of non-declared goldenseal leaf as an adulterant to goldenseal root/rhizome is rare. One analysis of hydrastine and berberine in goldenseal leaf found levels of these alkaloids ranging at 0.27-0.29% and 0.36-0.39%, respectively, while levels in the root were 2.25-3.32% and 2.61-3.75%, respectively. As part of this 2002 study, three commercial echinacea/goldenseal products were tested with one containing only berberine in the expected range of goldenseal-derived isoquinoline alkaloids, which may indicate an adulterant species was used. Another contained very low alkaloid content suggesting possible leaf adulteration.29
3.4 Accidental or intentional adulteration: Historically as well as recently, the use of adulterating species appears to be motivated primarily by economic gain,24-29 particularly when bulk goldenseal root is selling for up to $110 per kg.
3.5 Frequency of occurrence: There is no comprehensive study on the frequency of goldenseal adulteration. One analysis in 2003 of three lots of purchased commercial goldenseal root powder found goldenseal alkaloids hydrastinine, berberastine, tetrahydroberberastine, canadaline, berberine, hydrastine, and canadine in all samples, while only one sample from a single supplier also contained palmatine, coptisine, and jatrorrhizine, presumably indicating that adulteration with coptis occurred in that one sample.29
3.6 Possible therapeutic/safety issues: Although no systematic investigation into human toxic effects associated with the use of Berberis spp., Coptis spp., or M. aquifolium could be found, no other spontaneous or anecdotal reports of adverse effects could be found. The second edition of the American Herbal Products Association’s Botanical Safety Handbook (BSH2) lists B. Vulgaris and C. Chinensis as class 2b safety ingredients, meaning that these botanicals should not be used during pregnancy. The safety concerns in the BSH2 are based on studies using pure berberine, and may not directly apply to extracts made from barberry or coptis. Mahonia aquifolium, which also contains berberine, is presented as a safety class 1 ingredient, which is a botanical that is considered to be safe when used appropriately. Nevertheless, use of Oregon grape during pregnancy is not recommended. In addition, all berberine-containing plants are not recommended for use during lactation.35
Case studies of Chelidonium majus herb in Germany have associated consumption of the herb with liver toxicity. Ad hoc causality assessments in 22 spontaneous cases employing a liver-specific, standardized, quantitative assessment method (Council for International Organizations of Medical Sciences) found causality to be highly probable (n = 2), probable (n = 6), possible (n = 10), unlikely (n = 1), and excluded (n = 3). The pattern of liver injury was observed predominantly among female consumers. The average treatment was 36.4 days, and the latency period until first symptoms and jaundice was 29.8 and 35.6 days, respectively. The study did not identify which of the constituents were responsible for the liver injury.36 No product analysis was conducted and manufacturer observance of cGMP (current Good Manufacturing Practices) was assumed. As such, it is unknown if adulterated products impacted the reported adverse effects.
3.7 Analytical methods to detect adulteration: Brown and Roman conducted a multi-laboratory collaborative study utilizing an HPLC-ultraviolet (UV) detection method, previously validated using AOAC International single-laboratory validation guidelines, to measure hydrastine and berberine in goldenseal root raw materials, extracts, and dietary supplements at concentrations of 0.4 to 6% (w/w). In addition to the quantification of berberine and hydrastine, the method also detected the presence of palmatine, an indicator of adulteration with Coptis spp.33 Based on the results of the study the method was subsequently adopted as AOAC official method 2008.04-2008.37 Weber et al., generated different alkaloid profiles for H. Canadensis root and two berberine-containing Coptis species using a validated HPLC-MS method.38 Kamath and colleagues investigated alkaloid compositions of H. Canadensis, American goldthread (C. trifolia) and coptis (C. Chinensis). They determined that the spectrum of alkaloids in C. Chinensis was different from those in H. Canadensis and C. trifolia, showing that the alkaloid fingerprint was suitable to distinguish the species.39 Another HPLC-MS method was shown to separate 10 analytes (berbamine, berberine, canadine, chelerythrine, coptisine, hydrastinine, hydrastine, jatrorrhizine, palmatine, and sanguinarine) from six different plant species (H. Canadensis, Coptis japonica, B. vulgaris, Chelidonium majus, M. aquifolium andS. Canadensis), allowing analysts to quantify the presence of adulterants at concentrations as low as 5%.40More recently, a UPLC method with UV detection was used to identify the non-goldenseal constituents palmatine, coptisine, and jatrorrhizine in a commercial goldenseal product.34
Govindan and Govindan developed a thin-layer chromatography (TLC) method to detect hydrastine, hydrastinine, and berberine of several goldenseal preparations.41 Their analysis identified three samples containing only berberine and one sample that contained none of the alkaloids, potentially indicating economic adulteration. The results of the TLC analysis were confirmed by subsequent HPLC tests.41 The American Herbal Pharmacopoeia adopted a validated high-performance TLC (HPTLC) method that simultaneously detects palmatine, which is found in adulterants, plus berberine, hydrastine, and hydrastinine. Upton noted the usefulness of hydrastinine as a reliable marker for old or poor quality H. Canadensis, since it is formed as a degradation product of hydrastine.42 Finally, a TLC/desorption electrospray ionization (DESI)-MS method was shown to detect non-goldenseal alkaloids from adulterants in goldenseal products.43
Several official compendial methods exist that may also be applied to adulterant detection, including theEuropean Pharmacopoeia44 and the United States Pharmacopeia–National Formulary.45 Criteria to perform identification using macroscopic and microscopic examinations of goldenseal rhizome and root are presented in several references.42,44,45 In addition to the macroscopic and microscopic characteristics of goldenseal, the AHP monograph also lists such characteristics for Oregon grape, Coptis spp., yellow dock, and yellow root.42
Other, unique analytical systems have been developed that detect both major and minor H. canadensis alkaloids. These methods, including capillary electrophoresis-mass spectrometry (CE-MS),46 pH-zone-refining counter-current chromatography (CCC),47 shift subtracted Raman spectroscopy (SSRS),48 and an enzyme-linked immunosorbent assay (ELISA) linked to an HPLC,49 may be adapted for the detection of adulterants.
4 Conclusions: Habitat destruction in some areas of the eastern United States, goldenseal’s native range, has decreased the availability of this important medicinal plant. Pricing pressure has historically increased the incentive for economically motivated adulteration of goldenseal root. Although the actual extent of adulteration of goldenseal root and rhizome in the current market is not clear, a number of authenticated methods exist to detect such adulteration, including some that have been validated.
*Although it has sometimes been called wild Curcuma, goldenseal should not be confused with turmeric root (Curcuma longa, Zingiberaceae).
- Barton BS. Collections for an Essay Towards a Materia Medica of the United States. Philadelphia, PA: Way & Groff. 1798 &1804 (Part Second). Reprint: Bulletin of the Lloyd Library No. 1 Reproduction Series No. 1;1900.
- McGuffin M, Kartesz JT, Leung AY, Tucker AO. Herbs of Commerce. 2nd ed. Silver Spring, MD: American Herbal Products Association; 2000.
- Grieve M. A Modern Herbal. Vol. 1. Mineola, NY: Dover Publications; 1971. Available at: http://www.botanical.com/botanical/mgmh/g/golsea27.html. Accessed July 16, 2015.
- Gruenwald J, Brendler T, Jaenicke C, et al., eds. PDR for Herbal Medicines. 2nd ed. Montvale, NJ: Medical Economics Company, Inc.; 2000.
- United States Department of Agriculture (USDA), Agricultural Research Service (ARS), National Genetic Resources Program. Germplasm Resources Information Network (GRIN) Online Database. Beltsville, MD: National Germplasm Resources Laboratory. Available at: http://www.ars-grin.gov/cgi-bin/npgs/html/taxon.pl?19478. Accessed July 20, 2015.
- Guareschi I, ed. Commentario della Farmacopea Italiana e dei Medicamenti in Generale. Vol. 2, part 1, commentario E-M. Torino, Italy: Unione Tipografico; 1897: 315-317.
- Linnaeus C. Systema Naturae. Vol. 2. 10th ed. Holmiae: Laurentii Salvii;1758.
- Hydrastis canadensis. The Plant List website. Available at: http://www.theplantlist.org/tpl1.1/record/tro-27100410. Accessed June 26, 2015.
- Upton R, Graff A, Swisher D. Goldenseal root, Hydrastis canadensis L.: Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz, CA: American Herbal Pharmacopoeia; 2001.
- United States Pharmacopeial Convention. Powdered Goldenseal. In: USP 39-NF 34. Rockville, MD: United States Pharmacopeial Convention. 2016.
- Moerman DE. Medicinal Plants of Native America Vol. 1. Ann Arbor, MI: University of Michigan, Museum of Anthropology; 1988.
- Ellingwood F. American Materia Medica Therapeutics and Pharmacognosy.1919. Sandy, OR: Eclectic Medical Publications; 1983.
- Felter HW and Lloyd JU. King’s American Dispensatory. 1898. Sandy, OR: Eclectic Medical Publications; 1886.
- Lindstrom A, Ooyen C, Lynch ME, Blumenthal M, Kawa K. Sales of herbal dietary supplements increase by 7.9% in 2013, marking a decade of rising sales. HerbalGram. 2014;103:52-56. Available at: http://cms.herbalgram.org/herbalgram/issue103/HG103-mkrpt.html. Accessed May 19, 2016.
- Smith T, Lynch ME, Johnson J, Kawa K, Baumann H, Blumenthal M. Herbal dietary supplement sales in the US increase 6.8% in 2014. HerbalGram. 2015;107:52-59. Available at: http://cms.herbalgram.org/herbalgram/issue107/hg107-mktrpt-2014hmr.html. Accessed May 19, 2016.
- Oldfield S. IUCN/SSC Medicinal Plant Specialist Group PC 15 Inf. 3. Available at: http://www.cites.org/common/com/pc/15/X-PC15-03-Inf.pdf. Accessed July 26, 2015.
- CITES. Hydrastis Canadensis. Species database Available at http://www.cites.org/eng/app/appendices.php; 2012. Accessed July 17, 2015
- US Forest Service. Laws and regulations to protect endangered plants. The Convention on International Trade in Endangered Species of Wild Fauna and Flora. Available at: http://www.fs.fed.us/wildflowers/Rare_Plants/conservation/lawsandregulations.shtml. Accessed July 17, 2015.
- Plants Database [database online]. USDA Beltsville MD. Available at: http://www.embase.com.ezproxy.med.ucf.edu/home. Accessed July 16, 2015.
- Burkhart E. Goldenseal. Non-timber forest products (NTFPs) from Pennsylvania 2. State College, PA: Information and Communication Technologies in the College of Agricultural Sciences, Penn State University. Available at: http://extension.psu.edu/natural-resources/forests/botanicals/goldenseal/goldenseal; 2006. Accessed July 16, 2015.
- Pengelly A, Bennett K, Spelman K, Tims M. Appalachian plant monographs: Hydrastis Canadensis L., goldenseal. Appalachian Center for Ethnobotanical Studies; 2012. Available at http://www.frostburg.edu/fsu/assets/File/ACES/Hydrastis%20canadensis%20for%20ACES%20website.pdf. Accessed June 26, 2015.
- Dentali S, Zimmerman M. American Herbal Products Association Tonnage Surveys of Select North American Wild-Harvested Plants, 2006-2010. Silver Spring, MD: American Herbal Products Association; 2012.
- Lloyd JU, Lloyd CG. Drugs and Medicines of North America: Ranunculaceae. Cincinnati, OH: JU and CG Lloyd; 1884-85.
- Blaque G, Maheu J. Les falsifications actuelles de l’Hydrastis canadensis. Bull Sci Pharm. 1926;33,375-384.
- Collin ME. Note sur l’Hydrastis canadensis. J Pharm Chim. 1900;6(11):309-314.
- Blaschek W, Ebel S, Hackenthal E, et al., eds. Hydrastis rhizoma. In: HagerROM 2006: Hagers Handbuch der Drogen und Arzneistoffe. Version 5.0. Heidelberg, Germany: Springer Medizin Verlag. 2006.
- Betz JM, Musser SM, Larkin GM. Differentiation between goldenseal (Hydrastis Canadensis L.) and possible adulterants by LC/MS. Presented at: 39th Annual Meeting of the American Society of Pharmacognosy; July 1998; Orlando, FL.
- Wang MF, Zhu NQ, Jin Y, Belkowitz N, Ho CT. A Quantitative HPLC Method for the Quality Assurance of Goldenseal Products in the U.S. Market, in Quality Management of Nutraceuticals. In: Ho CT, Zheng Q, eds. ACS Symposium Series; 2002.
- Weber HA, Zart MK, Hodges AE, Molloy HM, O’Brien BM, Smith CS. Chemical comparison of goldenseal (Hydrastis Canadensis L.) roots powder from three commercial suppliers. J Agric Food Chem. 2003; 51(25):7352-7358.
- Mikkelsen SL, Ash KO. Adulterants causing false negatives in illicit drug testing. Clin Chem. 1988;34(11):2333-2336.
- AuthenTechnologies, Richmond CA. Case Study 1401: Fake Goldenseal is a Yellow Weed. Available at: http://www.authentechnologies.com/resources/case-studies/case-study-1401-fake-goldenseal/. Accessed July 17, 2015.
- Brinckmann J. Medicinal Plants and Extracts. Marketing News Service Quarterly. Dec. 2011. International Trade Centre. Available at: http://www.intracen.org/uploadedFiles/intracenorg/Content/Exporters/Market_Data_and_Information/Market_information/Market_Insider/Medicinal_plants/Medicinal%20Plants%20December%202011.pdf. Accessed August 13, 2015.
- Brown PN, Roman MC. Determination of hydrastine and berberine in goldenseal raw materials, extracts, and dietary supplements by high-performance liquid chromatography with UV: collaborative study, J AOAC Int. 2008;91(4):694–701.
- Avula B, Wang YH, Khan IA. Quantitative determination of alkaloids from the roots of Hydrastis Canadensis L. and dietary supplements using ultra-performance liquid chromatography with UV detection. J AOAC Int. 2012;95(5):1398-1405.
- Gardner Z, McGuffin M, eds. American Herbal Products Association’s Botanical Safety Handbook. 2nd ed. Boca Raton, FL: CRC Press; 2013:155-159.
- Teschke R, Glass X, Schulze J. Herbal hepatotoxicity by Greater Celandine (Chelidonium majus): Causality assessment of 22 spontaneous reports. RTP. 2011: 61(i3):282-291.
- Official Method 2008.04-2008, Hydrastine and berberine in goldenseal raw materials, extracts and dietary supplements. Official Methods of Analysis of AOAC International, 19th ed. Gaithersuburg, MD: AOAC International; 2012.
- Weber HA, Zart, MK, Hodges AE, et al. Method validation for determination of alkaloid content in goldenseal root powder. 2002; J AOAC Int 86:476.
- Kamath S, Skeels M, Pai A. Significant differences in the alkaloid content of Coptis Chinensis (Huanglian), from its related American species. Chinese Medicine. 2009;4:17.
- Tims MC. The chemical ecology of Hydrastis Canadensis L. (Ranunculaceae): Effects of root isoquinoline alkaloids on the Hydrastis endophyte, Fusarium oxysporum. 2006. Available at: http://drum.lib.umd.edu/handle/1903/4052. Accessed July 17, 2015.
- Govindan M, Govindan G. A convenient method for the determination of the quality of goldenseal. Fitoterapia. 2000;71(3):232-235.
- Upton R. American Herbal Pharmacopoeia and Therapeutic Compendium: Goldenseal root. Hydrastis Canadensis. Santa Cruz, CA: American Herbal Pharmacopoeia. 2001.
- Van Berkel GJ, Tomkins BA, Kertesz V. Thin-layer chromatography/desorption electrospray ionization mass spectrometry: investigation of goldenseal alkaloids. Anal Chem. 2007;79(7):2778-2789.
- The European Directorate for the Quality of Medicines & HealthCare. European Pharmacopoeia (EP 8.7). Hydrastis rhizoma. Strasbourg, France: Council of Europe; 2015.2963.
- United States Pharmacopeial Convention. Goldenseal. In: USP 39-NF 34. Rockville, MD: United States Pharmacopeial Convention. 2016.
- Sturm S, Stuppner H. Analysis of isoquinoline alkaloids in medicinal plants by capillary electrophoresis—mass spectrometry. Electrophoresis. 1998;19(16‐17): 3026-3032.
- Chadwick LR, Wu CD, Kinghorn AD. Isolation of alkaloids from goldenseal (Hydrastis Canadensis rhizomes) using pH-zone-refining countercurrent chromatography. J Liq Chromatogr Rel Technol. 2001; 2445-2453;24(16):2445-2453.
- Bell SE, Bourguignon ESO, Dennis AC, Fields JA, McGarvey JJ, Seddon KR. Identification of dyes on ancient Chinese paper samples using the subtracted shifted Raman spectroscopy method. Anal Chem. 2000;72:234-239.
- Kim JS, Tanaka H, Shoyama Y. Immunoquantitative analysis for berberine and its related compounds using monoclonal antibodies in herbal medicines. Analyst. 2003;129(1):87-91.